MicroRNA in diabetic nephropathy: Renin angiotensin, AGE/RAGE, and oxidative stress pathway

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Hagiwara, Shinji ^a,b   McClelland, Aaron ^a   Kantharidis, Phillip ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; MICRORNA;

ANIMAL; DIABETIC NEPHROPATHY; GENETICS; HUMAN; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DIABETIC NEPHROPATHIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MICRORNAS; OXIDATIVE STRESS; RECEPTORS, IMMUNOLOGIC; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 84893797069     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/173783     Document Type: Review

References (88)

1. Danaei G., Finucane M. M., Lu Y., Singh G. M., Cowan M. J., Paciorek C. J., Lin J. K., Farzadfar F., Khang Y.-H., Stevens G. A., Rao M., Ali M. K., Riley L. M., Robinson C. A., Ezzati M., National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2 · 7 million participants. The Lancet 2011 378 9785 31 40 2-s2.0-79959936188 10.1016/S0140-6736(11)60679-X
2. Stenvinkel P., Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. Journal of Internal Medicine 2010 268 5 456 467 2-s2.0-77958600480 10.1111/j.1365-2796.2010.02269.x
3. Sarnak M. J., Levey A. S., Schoolwerth A. C., Coresh J., Culleton B., Hamm L. L., McCullough P. A., Kasiske B. L., Kelepouris E., Klag M. J., Parfrey P., Pfeffer M., Raij L., Spinosa D. J., Wilson P. W., Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003 108 17 2154 2169 2-s2.0-0141468244 10.1161/01.CIR.0000095676. 90936.80 (Pubitemid 37337595)
4. Gilbertson D. T., Liu J., Xue J. L., Louis T. A., Solid C. A., Ebben J. P., Collins A. J., Projecting the number of patients with end-stage renal disease in the United States to the year 2015. Journal of the American Society of Nephrology 2005 16 12 3736 3741 2-s2.0-33645276928 10.1681/ASN.2005010112 (Pubitemid 46211296)
5. Cull C., Manley S., Frighi V., Holman R., Turner R., UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated Type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia. Diabetologia 1993 36 10 1021 1029 2-s2.0-0027431951 (Pubitemid 23288771)
6. Shamoon H., Duffy H., Fleischer N., Engel S., Saenger P., Strelzyn M., Litwak M., Wylie-Rosett J., Farkash A., Geiger D., Engel H., Fleischman J., Pompi D., Ginsberg N., Glover M., Brisman M., Walker E., Thomashunis A., Gonzalez J., The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993 329 14 977 986 2-s2.0-0027370108 10.1056/NEJM199309303291401 (Pubitemid 23307905)
7. Amico J. A., Klein I., Diabetic management in patients with renal failure. Diabetes Care 1981 4 3 430 434 2-s2.0-0019837206 (Pubitemid 12201601)
8. Cooper M. E., Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001 44 11 1957 1972 2-s2.0-0035204171 10.1007/s001250100000 (Pubitemid 33124041)
9. Soifer H. S., Rossi J. J., Sætrom P., MicroRNAs in disease and potential therapeutic applications. Molecular Therapy 2007 15 12 2070 2079 2-s2.0-36349032759 10.1038/sj.mt.6300311 (Pubitemid 350148921)
10. Stefani G., Slack F. J., Small non-coding RNAs in animal development. Nature Reviews Molecular Cell Biology 2008 9 3 219 230 2-s2.0-39749110083 10.1038/nrm2347 (Pubitemid 351301826)
11. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
12. Friedman R. C., Farh K. K.-H., Burge C. B., Bartel D. P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 2009 19 1 92 105 2-s2.0-60149095444 10.1101/gr.082701.108
13. Lee R. C., Feinbaum R. L., Ambros V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993 75 5 843 854 2-s2.0-0027751663 10.1016/0092-8674(93)90529-Y (Pubitemid 24014542)
14. Reinhart B. J., Slack F. J., Basson M., Pasquienelll A. E., Bettlnger J. C., Rougvle A. E., Horvitz H. R., Ruvkun G., The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000 403 6772 901 906 2-s2.0-0034708122 10.1038/35002607 (Pubitemid 30130993)
15. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T., Identification of novel genes coding for small expressed RNAs. Science 2001 294 5543 853 858 2-s2.0-0035955374 10.1126/science.1064921 (Pubitemid 33032103)
16. Lee Y., Kim M., Han J., Yeom K.-H., Lee S., Baek S. H., Kim V. N., MicroRNA genes are transcribed by RNA polymerase II. EMBO Journal 2004 23 20 4051 4060 2-s2.0-8144225486 10.1038/sj.emboj.7600385 (Pubitemid 39472426)
17. Baskerville S., Bartel D. P., Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 2005 11 3 241 247 2-s2.0-13944260434 10.1261/rna.7240905 (Pubitemid 40270816)
18. Kim Y.-K., Kim V. N., Processing of intronic microRNAs. EMBO Journal 2007 26 3 775 783 2-s2.0-33846945735 10.1038/sj.emboj.7601512
19. Rodriguez A., Griffiths-Jones S., Ashurst J. L., Bradley A., Identification of mammalian microRNA host genes and transcription units. Genome Research 2004 14 10 A 1902 1910 2-s2.0-6344281172 10.1101/gr.2722704 (Pubitemid 39386503)
20. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5 (Pubitemid 38167318)
21. Gregory R. I., Yan K.-P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R., The Microprocessor complex mediates the genesis of microRNAs. Nature 2004 432 7014 235 240 2-s2.0-9144225636 10.1038/nature03120 (Pubitemid 39545855)
22. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Rådmark O., Kim S., Kim V. N., The nuclear RNase III Drosha initiates microRNA processing. Nature 2003 425 6956 415 419 2-s2.0-0141843656 10.1038/nature01957 (Pubitemid 37187272)
23. Chendrimada T. P., Gregory R. I., Kumaraswamy E., Norman J., Cooch N., Nishikura K., Shiekhattar R., TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005 436 7051 740 744 2-s2.0-23644433363 10.1038/nature03868 (Pubitemid 41117280)
24. Small E. M., Olson E. N., Pervasive roles of microRNAs in cardiovascular biology. Nature 2011 469 7330 336 342 2-s2.0-78751660177 10.1038/nature09783
25. Hausser J., Syed A. P., Bilen B., Zavolan M., Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation. Genome Research 2013 23 4 604 615
26. Lee I., Ajay S. S., Jong I. Y., Hyun S. K., Su H. H., Nam H. K., Dhanasekaran S. M., Chinnaiyan A. M., Athey B. D., New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites. Genome Research 2009 19 7 1175 1183 2-s2.0-67650087599 10.1101/gr.089367.108
27. Guo H., Ingolia N. T., Weissman J. S., Bartel D. P., Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010 466 7308 835 840 2-s2.0-77955644289 10.1038/nature09267
28. Shyu A.-B., Wilkinson M. F., Van Hoof A., Messenger RNA regulation: to translate or to degrade. EMBO Journal 2008 27 3 471 481 2-s2.0-38949195105 10.1038/sj.emboj.7601977 (Pubitemid 351225677)
29. Diehl P., Fricke A., Sander L., Stamm J., Bassler N., Htun N., Ziemann M., Helbing T., El-Osta A., Jowett J. B. M., Peter K., Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovascular Research 2012 93 4 633 644 2-s2.0-84857975438 10.1093/cvr/cvs007
30. Lorenzen J. M., Haller H., Thum T., MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nature Reviews Nephrology 2011 7 5 286 294 2-s2.0-79955593914 10.1038/nrneph.2011.26
31. Sequeira López M. L. S., Pentz E. S., Nomasa T., Smithies O., Gomez R. A., Renin cells are precursors for multiple cell types that switch to the renin phenotype when homeostasis is threatened. Developmental Cell 2004 6 5 719 728 2-s2.0-2342512100 10.1016/S1534-5807(04)00134-0 (Pubitemid 38579354)
32. Sequeira-Lopez M. L. S., Weatherford E. T., Borges G. R., Monteagudo M. C., Pentz E. S., Harfe B. D., Carretero O., Sigmund C. D., Gomez R. A., The microRNA-processing enzyme dicer maintains juxtaglomerular cells. Journal of the American Society of Nephrology 2010 21 3 460 467 2-s2.0-77949905292 10.1681/ASN.2009090964
33. Marques F. Z., Campain A. E., Tomaszewski M., Zukowska-Szczechowska E., Yang Y. H. J., Charchar F. J., Morris B. J., Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension 2011 58 6 1093 1098 2-s2.0-83155175103 10.1161/HYPERTENSIONAHA.111.180729
34. Chen N. X., Kiattisunthorn K., O'Neill K.D., Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PloS ONE 2013 8 e64558
35. Jeppesen P. L., Christensen G. L., Schneider M., Nossent A. Y., Jensen H. B., Andersen D. C., Eskildsen T., Gammeltoft S., Hansen J. L., Sheikh S. P., Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes. British Journal of Pharmacology 2011 164 2 394 404 2-s2.0-80051981239 10.1111/j.1476-5381.2011.01375.x
36. Eskildsen T. V., Jeppesen P. L., Schneider M., Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans. International Journal of Molecular Sciences 2013 14 11190 11207
37. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C.-Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine 2004 351 13 1296 1370 2-s2.0-4644221457 10.1056/NEJMoa041031 (Pubitemid 39268908)
38. Fu M.-X., Wells-Knecht K. J., Blackledge J. A., Lyons T. J., Thorpe S. R., Baynes J. W., Glycation, glycoxidation, and cross-linking of collagen by glucose: kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes 1994 43 5 676 683 2-s2.0-0028223128 (Pubitemid 24138781)
39. Gu L., Hagiwara S., Fan Q., Tanimoto M., Kobata M., Yamashita M., Nishitani T., Gohda T., Ni Z., Qian J., Horikoshi S., Tomino Y., Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes. Nephrology Dialysis Transplantation 2006 21 2 299 313 2-s2.0-31544463531 10.1093/ndt/gfi210 (Pubitemid 43159982)
40. Shi S., Yu L., Chiu C., Sun Y., Chen J., Khitrov G., Merkenschlager M., Holzman L. B., Zhang W., Mundel P., Bottinger E. P., Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. Journal of the American Society of Nephrology 2008 19 11 2159 2169 2-s2.0-55749112141 10.1681/ASN.2008030312
41. Shanmugam N., Reddy M. A., Natarajan R., Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products. Journal of Biological Chemistry 2008 283 52 36221 36233 2-s2.0-61349083044 10.1074/jbc.M806322200
42. Li L.-M., Hou D.-X., Guo Y.-L., Yang J.-W., Liu Y., Zhang C.-Y., Zen K., Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes. Journal of Immunology 2011 186 4 2552 2560 2-s2.0-79951838008 10.4049/jimmunol.1001633
43. Mardente S., Mari E., Consorti F., HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells. Oncology Reports 2012 28 2285 2289
44. Liu X., Cheng Y., Zhang S., Lin Y., Yang J., Zhang C., A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circulation Research 2009 104 4 476 486 2-s2.0-61949252089 10.1161/CIRCRESAHA.108.185363
45. Togliatto G., Trombetta A., Dentelli P., Rosso A., Brizzi M. F., MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage. Diabetologia 2011 54 7 1930 1940 2-s2.0-79959691141 10.1007/s00125-011-2125-5
46. Fiorentino L., Cavalera M., Mavilio M., Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs. Acta Diabetologica 2013
47. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., Mercatanti A., Hammond S., Rainaldi G., MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006 108 9 3068 3071 2-s2.0-33751173635 10.1182/blood-2006-01-012369
48. Li Y., Song Y.-H., Li F., Yang T., Lu Y. W., Geng Y.-J., microRNA-221 regulates high glucose-induced endothelial dysfunction. Biochemical and Biophysical Research Communications 2009 381 1 81 83 2-s2.0-61849179809 10.1016/j.bbrc.2009.02.013
49. Suárez Y., Fernández-Hernando C., Pober J. S., Sessa W. C., Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circulation Research 2007 100 8 1164 1173 2-s2.0-34247554263 10.1161/01.RES.0000265065.26744.17 (Pubitemid 46684129)
50. Zhu N., Zhang D., Chen S., Liu X., Lin L., Huang X., Guo Z., Liu J., Wang Y., Yuan W., Qin Y., Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis 2011 215 2 286 293 2-s2.0-79953057954 10.1016/j.atherosclerosis.2010.12.024
51. Bashan N., Kovsan J., Kachko I., Ovadia H., Rudich A., Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiological Reviews 2009 89 1 27 71 2-s2.0-58249110569 10.1152/physrev.00014.2008
52. Kaneto H., Katakami N., Kawamori D., Miyatsuka T., Sakamoto K., Matsuoka T.-A., Matsuhisa M., Yamasaki Y., Involvement of oxidative stress in the pathogenesis of diabetes. Antioxidants and Redox Signaling 2007 9 3 355 366 2-s2.0-33846434443 10.1089/ars.2006.1465 (Pubitemid 46145981)
53. Gill P. S., Wilcox C. S., NADPH oxidases in the kidney. Antioxidants and Redox Signaling 2006 8 9-10 1597 1607 2-s2.0-33750919240 10.1089/ars.2006.8.1597 (Pubitemid 44726334)
54. Palicz A., Foubert T. R., Jesaitis A. J., Marodi L., McPhail L. C., Phosphatidic acid and diacylglycerol directly activate NADPH oxidase by interacting with enzyme components. Journal of Biological Chemistry 2001 276 5 3090 3097 2-s2.0-0035793541 10.1074/jbc.M007759200
55. Sedeek M., Callera G., Montezano A., Gutsol A., Heitz F., Szyndralewiez C., Page P., Kennedy C. R. J., Burns K. D., Touyz R. M., Hébert R. L., Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. American Journal of Physiology. Renal Physiology 2010 299 6 F1348 F1358 2-s2.0-78649913769 10.1152/ajprenal.00028.2010
56. Forbes J. M., Coughlan M. T., Cooper M. E., Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008 57 6 1446 1454 2-s2.0-48249085391 10.2337/db08-0057
57. Eid A. A., Gorin Y., Fagg B. M., Maalouf R., Barnes J. L., Block K., Abboud H. E., Mechanisms of podocyte injury in diabetes role of cytochrome P450 and NADPH oxidases. Diabetes 2009 58 5 1201 1211 2-s2.0-65549157823 10.2337/db08-1536
58. Wang Q., Wang Y., Minto A. W., Wang J., Shi Q., Li X., Quigg R. J., MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB Journal 2008 22 12 4126 4135 2-s2.0-57349186092 10.1096/fj.08-112326
59. Chhabra R., Adlakha Y. K., Hariharan M., Scaría V., Saini N., Upregulation of miR-23a 27a 24-2 cluster induces caspase-dependent and -independent apoptosis in human embryonic kidney cells. PLoS ONE 2009 4 6 2-s2.0-67649217148 10.1371/journal.pone.0005848 e5848
60. Chhabra R., Dubey R., Saini N., Gene expression profiling indicate role of ER stress in miR-23a27a24-2 cluster induced apoptosis in HEK293T cells. RNA Biology 2011 8 4 648 664 2-s2.0-84859882421
61. Shang H., Nitsche E., Jing X., Inhibition of TGF-b signaling by miR-23b. Journal of the American Society of Nephrology 2008 143A
62. Rao G., Xia E., Richardson A., Effect of age on the expression of antioxidant enzymes in male Fischer F344 rats. Mechanisms of Ageing and Development 1990 53 1 49 60 2-s2.0-0025248785 10.1016/0047-6374(90)90033-C (Pubitemid 20087892)
63. Meng Q., Wong Y. T., Chen J., Ruan R., Age-related changes in mitochondrial function and antioxidative enzyme activity in fischer 344 rats. Mechanisms of Ageing and Development 2007 128 3 286 292 2-s2.0-33846869739 10.1016/j.mad.2006.12.008 (Pubitemid 46227547)
64. Bai X.-Y., Ma Y., Ding R., Fu B., Shi S., Chen X.-M., miR-335 and miR-34a promote renal senescence by suppressing mitochondrial antioxidative enzymes. Journal of the American Society of Nephrology 2011 22 7 1252 1261 2-s2.0-79960140833 10.1681/ASN.2010040367
65. Mattiasson G., Sullivan P. G., The emerging functions of UCP2 in health, disease, and therapeutics. Antioxidants and Redox Signaling 2006 8 1-2 1 38 2-s2.0-33644639853 10.1089/ars.2006.8.1 (Pubitemid 43324527)
66. Pi J., Bai Y., Daniel K. W., Liu D., Lyght O., Edelstein D., Brownlee M., Corkey B. E., Collins S., Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic β -cell function. Endocrinology 2009 150 7 3040 3048 2-s2.0-67649641804 10.1210/en.2008-1642
67. Di Castro S., Scarpino S., Marchitti S., Differential modulation of uncoupling protein 2 in kidneys of stroke-prone spontaneously hypertensive rats under high-salt/low-potassium diet. Hypertension 2013 61 534 541
68. Gregory P. A., Bert A. G., Paterson E. L., Barry S. C., Tsykin A., Farshid G., Vadas M. A., Khew-Goodall Y., Goodall G. J., The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature Cell Biology 2008 10 5 593 601 2-s2.0-43049103824 10.1038/ncb1722 (Pubitemid 351627379)
69. Muratsu-Ikeda S., Nangaku M., Ikeda Y., Downregulation of miR-205 modulates cell susceptibility to oxidative and endoplasmic reticulum stresses in renal tubular cells. PloS ONE 2012 7 e41462
70. Magenta A., Cencioni C., Fasanaro P., Zaccagnini G., Greco S., Sarra-Ferraris G., Antonini A., Martelli F., Capogrossi M. C., MiR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death and Differentiation 2011 18 10 1628 1639 2-s2.0-80052700964 10.1038/cdd.2011.42
71. Mateescu B., Batista L., Cardon M., Gruosso T., De Feraudy Y., Mariani O., Nicolas A., Meyniel J.-P., Cottu P., Sastre-Garau X., Mechta-Grigoriou F., MiR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nature Medicine 2011 17 12 1627 1635 2-s2.0-84856111309 10.1038/nm.2512
72. Baseler W. A., Thapa D., Jagannathan R., Dabkowski E. R., Croston T. L., Hollander J. M., miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart. American Journal of Physiology. Cell Physiology 2012 303 C1244 C1251
73. Lin Y., Liu X., Cheng Y., Yang J., Huo Y., Zhang C., Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. Journal of Biological Chemistry 2009 284 12 7903 7913 2-s2.0-65249115670 10.1074/jbc.M806920200
74. Weber M., Baker M. B., Moore J. P., Searles C. D., MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochemical and Biophysical Research Communications 2010 393 4 643 648 2-s2.0-77949488939 10.1016/j.bbrc.2010.02.045
75. Fleissner F., Jazbutyte V., Fiedler J., Gupta S. K., Yin X., Xu Q., Galuppo P., Kneitz S., Mayr M., Ertl G., Bauersachs J., Thum T., Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a MicroRNA-21- Dependent mechanism. Circulation Research 2010 107 1 138 143 2-s2.0-77954758345 10.1161/CIRCRESAHA.110.216770
76. Liu F., Lou Y.-L., Wu J., Ruan Q.-F., Xie A., Guo F., Cui S.-P., Deng Z.-F., Wang Y., Upregulation of microRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling pathway under ischemia/perfusion injury in vivo and in vitro. Kidney and Blood Pressure Research 2012 35 3 182 191 2-s2.0-82055200555 10.1159/000331054
77. Park S.-M., Gaur A. B., Lengyel E., Peter M. E., The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes and Development 2008 22 7 894 907 2-s2.0-41649091906 10.1101/gad.1640608 (Pubitemid 351482843)
78. Korpal M., Lee E. S., Hu G., Kang Y., The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. Journal of Biological Chemistry 2008 283 22 14910 14914 2-s2.0-47249091921 10.1074/jbc.C800074200
79. Park J. T., Kato M., Yuan H., FOG2 protein down-regulation by transforming growth factor-beta1-induced microRNA-200b/c leads to Akt kinase activation and glomerular mesangial hypertrophy related to diabetic nephropathy. The Journal of Biological Chemistry 2013 288 22469 22480
80. Zhou J., Wang K.-C., Wu W., Subramaniam S., Shyy J. Y.-J., Chiu J.-J., Li J. Y.-S., Chien S., MicroRNA-21 targets peroxisome proliferators-activated receptor- α in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proceedings of the National Academy of Sciences of the United States of America 2011 108 25 10355 10360 2-s2.0-79959973595 10.1073/pnas.1107052108
81. Zhong X., Chung A. C., Chen H. Y., miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 2013 56 663 674
82. Zhang Z., Peng H., Chen J., Chen X., Han F., Xu X., He X., Yan N., MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Letters 2009 583 12 2009 2014 2-s2.0-67349089523 10.1016/j.febslet.2009.05.021
83. Chung A. C. K., Dong Y., Yang W., Zhong X., Li R., Lan H. Y., Smad7 suppresses renal fibrosis via altering expression of TGF- β /Smad3-regulated microRNAs. Molecular Therapy 2013 21 388 398
84. Zhong X., Chung A. C. K., Chen H.-Y., Meng X.-M., Lan H. Y., Smad3-mediated upregulation of miR-21 promotes renal fibrosis. Journal of the American Society of Nephrology 2011 22 9 1668 1681 2-s2.0-80052316668 10.1681/ASN.2010111168
85. Godwin J. G., Ge X., Stephan K., Jurisch A., Tullius S. G., Iacomini J., Identification of a microRNA signature of renal ischemia reperfusion injury. Proceedings of the National Academy of Sciences of the United States of America 2010 107 32 14339 14344 2-s2.0-77956279443 10.1073/pnas.0912701107
86. Saal S., Harvey S. J., MicroRNAs and the kidney: coming of age. Current Opinion in Nephrology and Hypertension 2009 18 4 317 323 2-s2.0-67849099709 10.1097/MNH.0b013e32832c9da2
87. Chan S. Y., Loscalzo J., MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 2010 9 6 1072 1083 2-s2.0-77953483108
88. Devlin C., Greco S., Martelli F., Ivan M., MiR-210: more than a silent player in hypoxia. IUBMB Life 2011 63 2 94 100 2-s2.0-79952137486 10.1002/iub.427